GlassScriptPhysician profile
Megan E Mayes
NPI 1003311309
$5,665.40
in general payments reported to CMS, 2019-2025
44 companies · $1,079 in 2025
The $1,079 reported for 2025 was more than what 86% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,164 · 2022: $549 · 2023: $1,581 · 2024: $1,293 · 2025: $1,079.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,883 · Education: $68.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,883.46 |
| Education | $68.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $918.54 | 2021-2025 | |
| Axsome Therapeutics, INC. | $447.99 | 2023-2025 | Auvelity, Symbravo |
| Otsuka America Pharmaceutical, INC. | $441.93 | 2021-2025 | Rexulti, Abilify Maintena |
| Amgen INC. | $344.25 | 2022-2025 | Tavneos, Repatha, Otezla |
| Novo Nordisk INC | $267.86 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $247.66 | 2021-2025 | Caplyta |
| Phathom Pharmaceuticals, INC. | $209.83 | 2024 | Voquezna |
| Dexcom, INC. | $201.78 | 2021-2024 | Dexcom G6 Transmitter |
| Myriad Women'S Health, INC. | $196.09 | 2023 | Myrisk |
| Glaxosmithkline, LLC. | $185.89 | 2022-2025 | Benlysta, Shingrix, Arexvy |
| Astrazeneca Pharmaceuticals LP | $169.68 | 2024-2025 | Airsupra, Farxiga |
| Corium, LLC | $163.98 | 2022-2025 | Azstarys, Azstarys |
| Corcept Therapeutics | $153.54 | 2025 | Korlym |
| Teva Pharmaceuticals USA, INC. | $151.18 | 2023-2025 | Austedo Xr, Austedo Xr |
| Abiomed | $144.13 | 2025 |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Megan Mayes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.